Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04351347

The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

Clinical Study Evaluating the Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

Status
Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
—
Healthy volunteers
Not accepted

Summary

Efficacy of Ivermectin in larger doses in COVID-19 treatment

Detailed description

Clinical Study Evaluating the Efficacy of Ivermectin in higher doses in COVID-19 treatment

Conditions

Interventions

TypeNameDescription
DRUGIvermectinivermectin

Timeline

Start date
2020-06-16
Primary completion
2030-12-01
Completion
2030-12-01
First posted
2020-04-17
Last updated
2021-03-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04351347. Inclusion in this directory is not an endorsement.